Weisiger R A
Department of Medicine, University of California, San Francisco 94143-0538, USA.
Hepatology. 1996 Nov;24(5):1288-95. doi: 10.1002/hep.510240550.
After entering the cell, small molecules must penetrate the cytoplasm before they are metabolized, excreted, or can convey information to the cell nucleus. Without efficient cytoplasmic transport, most such molecules would efflux back out of the cell before they could reach their targets. Cytoplasmic movement of amphipathic molecules (e.g., long-chain fatty acids, bilirubin, bile acids) is greatly slowed by their tendency to bind intracellular structures. Soluble cytoplasmic binding proteins reduce this binding by increasing the aqueous solubility of their ligands. These soluble carriers catalyze the transport of hydrophobic molecules across hydrophilic water layers, just as membrane carriers catalyze the transport of hydrophilic molecules across the hydrophobic membrane core. They even display the kinetic features of carrier-mediated transport, including saturation, mutual competition between similar molecules, and countertransport. Recent data suggest that amphipathic molecules cross the cytoplasm very slowly, with apparent diffusion constants 10(2) to 10(4) times smaller than in water. By modulating the rate of cytoplasmic transport, cytosolic binding proteins may regulate transport and metabolism of amphipathic molecules. Storage diseases may cause hepatocellular dysfunction by disrupting normal cytoplasmic transport.
进入细胞后,小分子在被代谢、排泄或向细胞核传递信息之前,必须穿透细胞质。如果没有高效的细胞质运输,大多数此类分子在到达目标之前就会流出细胞。两亲性分子(如长链脂肪酸、胆红素、胆汁酸)的细胞质移动会因它们与细胞内结构结合的倾向而大大减慢。可溶性细胞质结合蛋白通过增加其配体的水溶性来减少这种结合。这些可溶性载体催化疏水分子穿过亲水性水层,就像膜载体催化亲水性分子穿过疏水性膜核心一样。它们甚至表现出载体介导运输的动力学特征,包括饱和、相似分子之间的相互竞争和反向运输。最近的数据表明,两亲性分子穿过细胞质的速度非常慢,其表观扩散常数比在水中小10²到10⁴倍。通过调节细胞质运输速率,胞质结合蛋白可能调节两亲性分子的运输和代谢。储存疾病可能通过破坏正常的细胞质运输而导致肝细胞功能障碍。